CD4 and CD30 Coexpression in a Cutaneous Manifestation of Systemic Mastocytosis - A Pitfall

被引：1
|
作者：
Kulberg, Aleksandra [1 ]
Mitteldorf, Christina [1 ]
机构：
[1] HELIOS Klin, Dept Dermatol Venereol & Allergol, Hildesheim, Germany
来源：
AMERICAN JOURNAL OF DERMATOPATHOLOGY | 2018年 / 40卷 / 08期
关键词：
MAST-CELLS; EXPRESSION; RECEPTOR; MEMBER;
D O I：
10.1097/DAD.0000000000000895
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：628 / 630
页数：4
相关论文
共 50 条
  • [21] In rheumatoid arthritis soluble CD30 ligand is present at high levels and induces apoptosis of CD30+T cells
    Tinazzi, Elisa
    Barbieri, Alessandro
    Rigo, Antonella
    Patuzzo, Giuseppe
    Beri, Ruggero
    Gerli, Roberto
    Argentino, Giuseppe
    Puccetti, Antonio
    Lunardi, Claudio
    IMMUNOLOGY LETTERS, 2014, 161 (02) : 236 - 240
  • [22] Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases
    Ruggeri, RM
    Barresi, G
    Sciacchitano, S
    Trimarchi, F
    Benvenga, S
    Trovato, M
    HISTOLOGY AND HISTOPATHOLOGY, 2006, 21 (03) : 249 - 256
  • [23] A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb
    Wu, Yang
    Chen, Dan
    Lu, Ya
    Dong, Shu-Chen
    Ma, Rong
    Tang, Wei-yan
    Wu, Jian-qiu
    Feng, Ji-Feng
    Wu, Jian-Zhong
    CANCER GENE THERAPY, 2022, 29 (02) : 167 - 177
  • [24] Imbalance in serum soluble CD30/CD3OL and CD40/CD4OL systems are associated with ovarian tumors
    Mielczarek-Palacz, Aleksandra
    Sikora, Justyna
    Kondera-Anasz, Zdzislawa
    Hauza, Grzegorz
    HUMAN IMMUNOLOGY, 2013, 74 (01) : 70 - 74
  • [25] CD30 and PD-1 in mycosis fungoides
    Inan, Mehmet
    Ogut, Betul
    Gurer, Mehmet
    Erdem, Ozlem
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2023, 17 (03): : 93 - 99
  • [26] Targeting CD30 in Anaplastic Large Cell Lymphoma
    Vadakara, Joseph
    Pro, Barbara
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (04) : 285 - 291
  • [27] Diagnostic, prognostic and therapeutic role of CD30 in lymphoma
    Pierce, John Matthew R.
    Mehta, Amitkumar
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (01) : 29 - 37
  • [28] CD30 Is a Potential Therapeutic Target in Malignant Mesothelioma
    Dabir, Snehal
    Kresak, Adam
    Yang, Michael
    Fu, Pingfu
    Wildey, Gary
    Dowlati, Afshin
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (03) : 740 - 746
  • [29] The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
    Dumitru, Adrian Vasile
    Tapoi, Dana Antonia
    Halcu, Georgian
    Munteanu, Octavian
    Dumitrascu, David-Ioan
    Ceausu, Mihail Constantin
    Gheorghisan-Galateanu, Ancuta-Augustina
    CELLS, 2023, 12 (13)
  • [30] CD30, another useful predictor of survival in DLBCL?
    Chan, Wing C.
    BLOOD, 2013, 121 (14) : 2582 - 2583
12345